• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
In situ forming formulation: development, evaluation, and optimization using 3(3) factorial design.原位形成制剂:使用 3(3) 析因设计进行开发、评估和优化。
AAPS PharmSciTech. 2009;10(3):977-84. doi: 10.1208/s12249-009-9285-3. Epub 2009 Jul 28.
2
Formulation development of ambroxol hydrochloride soft gel with application of statistical experimental design and response surface methodology.应用统计实验设计和响应面法开发盐酸氨溴索软胶囊剂
PDA J Pharm Sci Technol. 2011 Jan-Feb;65(1):20-31.
3
Gastroretentive drug delivery of metformin hydrochloride: formulation and in vitro evaluation using 3(2) full factorial design.盐酸二甲双胍的胃滞留药物递送:使用 3(2)完全因子设计的制剂和体外评价。
Curr Drug Deliv. 2009 Oct;6(5):477-85. doi: 10.2174/156720109789941641.
4
Gamma scintigraphic study of the hydrodynamically balanced matrix tablets of Metformin HCl in rabbits.盐酸二甲双胍流体动力学平衡型骨架片在兔体内的γ闪烁扫描研究。
Drug Des Devel Ther. 2015 Jun 19;9:3125-39. doi: 10.2147/DDDT.S82935. eCollection 2015.
5
Sodium alginate microspheres of metformin HCl: formulation and in vitro evaluation.盐酸二甲双胍海藻酸钠微球:制剂与体外评价
Curr Drug Deliv. 2007 Jul;4(3):249-56. doi: 10.2174/156720107781023875.
6
Design and development of polymethylmethacrylate-grafted gellan gum (PMMA-g-GG)-based pH-sensitive novel drug delivery system for antidiabetic therapy.聚甲基丙烯酸甲酯接枝结冷胶(PMMA-g-GG)基 pH 敏感新型药物传递系统用于抗糖尿病治疗的设计与开发。
Drug Deliv Transl Res. 2020 Aug;10(4):1002-1018. doi: 10.1007/s13346-020-00776-7.
7
Oral controlled release formulation for highly water-soluble drugs: drug--sodium alginate--xanthan gum--zinc acetate matrix.用于高水溶性药物的口服控释制剂:药物 - 海藻酸钠 - 黄原胶 - 醋酸锌基质
Drug Dev Ind Pharm. 2004 May;30(5):491-5. doi: 10.1081/ddc-120037479.
8
Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies.采用 Box-Behnken 设计优化新型原位凝胶用于眼部药物缓释:体外、离体、体内和人体研究。
Int J Pharm. 2019 Jan 10;554:264-275. doi: 10.1016/j.ijpharm.2018.11.016. Epub 2018 Nov 10.
9
[Formulation by design of experiments of immediate release tablets with metformin hydrochloride and glibenclamide].[盐酸二甲双胍和格列本脲速释片的实验设计配方]
Rev Med Chir Soc Med Nat Iasi. 2010 Oct-Dec;114(4):1219-26.
10
Formulation and development of hydrodynamically balanced system for metformin: in vitro and in vivo evaluation.二甲双胍流体动力学平衡系统的制剂与研发:体外和体内评价
Eur J Pharm Biopharm. 2007 Aug;67(1):196-201. doi: 10.1016/j.ejpb.2006.12.015. Epub 2006 Dec 28.

引用本文的文献

1
The development of an in-situ biopolymer-based floating gel for the oral delivery of metformin hydrochloride.用于口服递送盐酸二甲双胍的原位生物聚合物基漂浮凝胶的研发。
Heliyon. 2023 Mar 23;9(4):e14796. doi: 10.1016/j.heliyon.2023.e14796. eCollection 2023 Apr.
2
Development of Carbamazepine Nanostructured Lipid Carrier Loaded Thermosensitive Gel for Intranasal Delivery.用于鼻内给药的卡马西平纳米结构脂质载体负载热敏凝胶的研制
Adv Pharm Bull. 2021 Jan;11(1):150-162. doi: 10.34172/apb.2021.016. Epub 2020 Nov 7.
3
Emerging Applications of Drug Delivery Systems in Oral Infectious Diseases Prevention and Treatment.药物传递系统在口腔传染病防治中的新应用。
Molecules. 2020 Jan 24;25(3):516. doi: 10.3390/molecules25030516.
4
Gastroretentive raft liquid delivery system as a new approach to release extension for carrier-mediated drug.胃滞留筏型液体给送系统——一种新的载体介导药物释放延长方法
Drug Deliv. 2018 Nov;25(1):1161-1174. doi: 10.1080/10717544.2018.1474969.
5
Development of topical ophthalmic In Situ gel-forming estradiol delivery system intended for the prevention of age-related cataracts.用于预防年龄相关性白内障的局部眼用原位凝胶形成雌二醇递送系统的研发。
PLoS One. 2017 Feb 21;12(2):e0172306. doi: 10.1371/journal.pone.0172306. eCollection 2017.
6
Xyloglucan Based In Situ Gel of Lidocaine HCl for the Treatment of Periodontosis.用于治疗牙周病的盐酸利多卡因木葡聚糖原位凝胶
J Pharm (Cairo). 2016;2016:3054321. doi: 10.1155/2016/3054321. Epub 2016 Jan 28.
7
Full factorial design for optimization, development and validation of HPLC method to determine valsartan in nanoparticles.用于优化、开发和验证测定纳米颗粒中缬沙坦的高效液相色谱法的全因子设计。
Saudi Pharm J. 2015 Oct;23(5):549-55. doi: 10.1016/j.jsps.2015.02.001. Epub 2015 Mar 3.
8
QbD-Enabled Development of Novel Stimuli-Responsive Gastroretentive Systems of Acyclovir for Improved Patient Compliance and Biopharmaceutical Performance.基于质量源于设计(QbD)理念开发新型阿昔洛韦刺激响应性胃滞留系统,以提高患者顺应性和生物药剂学性能。
AAPS PharmSciTech. 2016 Apr;17(2):454-65. doi: 10.1208/s12249-015-0367-0. Epub 2015 Aug 4.
9
Introduction of a mathematical model for optimizing the drug release in the patient's body.引入一个数学模型,用于优化患者体内的药物释放。
Daru. 2014 Jan 3;22(1):1. doi: 10.1186/2008-2231-22-1.
10
Gelucire based in situ gelling emulsions: a potential carrier for sustained stomach specific delivery of gastric irritant drugs.基于Gelucire的原位凝胶乳液:一种用于胃刺激性药物持续胃特异性递送的潜在载体。
Biomed Res Int. 2013;2013:436932. doi: 10.1155/2013/436932. Epub 2013 Nov 10.

本文引用的文献

1
Development of polysaccharide gel-coated pellets for oral administration. 2. Calcium alginate.用于口服给药的多糖凝胶包衣微丸的研制。2. 海藻酸钙。
Eur J Pharm Sci. 2006 Oct 1;29(2):139-47. doi: 10.1016/j.ejps.2006.06.007. Epub 2006 Jun 27.
2
Study of formulation variables influencing the drug release rate from matrix tablets by experimental design.通过实验设计研究影响基质片剂药物释放速率的处方变量。
Eur J Pharm Biopharm. 2006 Jan;62(1):77-84. doi: 10.1016/j.ejpb.2005.07.001. Epub 2005 Sep 8.
3
Application of experimental design methodology in development and optimization of drug release method.实验设计方法在药物释放方法开发与优化中的应用。
Int J Pharm. 2005 Mar 3;291(1-2):39-49. doi: 10.1016/j.ijpharm.2004.07.041. Epub 2005 Jan 12.
4
MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.缓释药物的作用机制。分散于固体基质中的固体药物释放速率的理论分析。
J Pharm Sci. 1963 Dec;52:1145-9. doi: 10.1002/jps.2600521210.
5
Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations.对乙酰氨基酚从原位凝胶结冷胶和海藻酸钠制剂中的口服持续释放。
Int J Pharm. 2003 Jun 4;258(1-2):55-64. doi: 10.1016/s0378-5173(03)00163-7.
6
Preparation of alginate beads for floating drug delivery system: effects of CO(2) gas-forming agents.用于漂浮药物递送系统的海藻酸钠珠粒的制备:二氧化碳气体形成剂的影响
Int J Pharm. 2002 Jun 4;239(1-2):81-91. doi: 10.1016/s0378-5173(02)00054-6.
7
Comparison of in situ gelling formulations for the oral delivery of cimetidine.西咪替丁口服原位凝胶制剂的比较
Int J Pharm. 2001 Jun 4;220(1-2):161-8. doi: 10.1016/s0378-5173(01)00669-x.
8
Robustness testing, using experimental design, of a flow-through dissolution method for a product where the actives have markedly differing solubility properties.使用实验设计对一种产品的流通溶解方法进行稳健性测试,该产品中的活性成分具有明显不同的溶解性。
Int J Pharm. 2000 Sep 25;206(1-2):55-61. doi: 10.1016/s0378-5173(00)00509-3.
9
Optimisation of floating matrix tablets and evaluation of their gastric residence time.漂浮型骨架片的优化及其胃滞留时间的评估。
Int J Pharm. 2000 Feb 15;195(1-2):125-35. doi: 10.1016/s0378-5173(99)00378-6.
10
Food intake and dosage level, but not tablet vs solution dosage form, affect the absorption of metformin HCl in man.食物摄入量和剂量水平会影响盐酸二甲双胍在人体中的吸收,但片剂与溶液剂型不会对此产生影响。
Br J Clin Pharmacol. 1996 Oct;42(4):510-2. doi: 10.1111/j.1365-2125.1996.tb00017.x.

原位形成制剂:使用 3(3) 析因设计进行开发、评估和优化。

In situ forming formulation: development, evaluation, and optimization using 3(3) factorial design.

机构信息

Department of Pharmaceutics, Institute of Technology, Banaras Hindu University, Varanasi 221005, India.

出版信息

AAPS PharmSciTech. 2009;10(3):977-84. doi: 10.1208/s12249-009-9285-3. Epub 2009 Jul 28.

DOI:10.1208/s12249-009-9285-3
PMID:19636710
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2802170/
Abstract

The present investigation concerns with the development and optimization of an in situ forming formulation using 3(3) full factorial design experimentation. Metformin, an antidiabetic drug with upper part of gastrointestinal tract as absorption window was used as a model drug. The formulations were designed with an objective to retain in stomach for an extended time period. The effect of three independent factors--concentrations of sodium alginate (X(1)), gellan gum (X(2)), and metformin (X(3)) on in vitro drug release were used to characterize and optimize the formulation. Five dependent variables-release exponent (Y(1)), dissolution efficiency (Y(2)), drug release at 30 min (Y(3)), 210 min (Y(4)), and 480 min (Y(5)) were considered as optimization factors. The data were statistically analyzed using ANOVA, and a p < 0.05 was considered statistically significant. Three dimensional surface response plots were drawn to evaluate the interaction of independent variables on the chosen dependent variables. Of the prepared 27 formulations, the responses exhibited by batch F17 containing medium level sodium alginate (X(1)), low level gellan (X(2)), and medium level metformin (X(3)) were similar to the predicted responses.

摘要

本研究采用 3(3) 全因子设计实验,致力于开发和优化原位形成制剂。二甲双胍是一种具有上胃肠道吸收窗的抗糖尿病药物,被用作模型药物。制剂设计的目的是延长在胃中的停留时间。三个独立因素——海藻酸钠浓度(X(1))、结冷胶浓度(X(2))和二甲双胍浓度(X(3))对体外药物释放的影响,用于对制剂进行特征描述和优化。五个因变量——释放指数(Y(1))、溶解效率(Y(2))、30 分钟时的药物释放(Y(3))、210 分钟时的药物释放(Y(4))和 480 分钟时的药物释放(Y(5))被视为优化因素。数据采用方差分析进行统计学分析,p < 0.05 被认为具有统计学意义。绘制了三维表面响应图,以评估独立变量对所选因变量的相互作用。在所制备的 27 种制剂中,含有中水平海藻酸钠(X(1))、低水平结冷胶(X(2))和中水平二甲双胍(X(3))的批次 F17 的响应与预测响应相似。